Dialog welcomes merger with NXL Architects

Monday, November 1, 2021

Dialog welcomes the merger with NXL Architects, a Canadian leader in the planning and design of laboratories and complex-process facilities for science, technology, and clean industry.

“Dialog and NXL share a culture that is genuinely collegial and collaborative,” said Jim Anderson, Dialog partner and chair. “Together, we bring an exceptional depth of experience and creative ingenuity to 21st century workplaces that contribute to the wellbeing of our communities and the sustainability of our environment.”

The merger with NXL expands Dialog’s science and technology practice, which has underway or recently completed the National Institute for Nanotechnology at the University of Alberta, research laboratories at the Calgary Cancer Centre, and a nation-wide renewal of Laboratories Canada facilities.

In addition to major research laboratories for University of Toronto, York University, Ryerson University, Carleton University, UBC, and the University Health Network, NXL has completed more than four million square feet of complex process facilities for companies such as Novopharm (now Teva) Pharmaceuticals, Eurofins CDMO Alphora, Therapure BioPharma Inc., EmpowerPharm, and Septodont Canada.

“By joining forces, we can deliver projects for our clients at a larger scale and complexity and across a broader geographic reach,” said Jay Levine, Dialog partner and NXL founding principal. “We want to help grow a Canadian science and technology ecosystem by bringing together public institutions, private enterprise, and the development community.”

Levine joins the firm as partner and science and technology sector lead. He is based in the Toronto studio and will work with teams across the practice in San Francisco, Vancouver, Calgary, Edmonton, and Toronto.

Leave a Reply

Your email address will not be published. Required fields are marked *

In our efforts to deter spam comments, please type in the missing part of this simple calculation: *Time limit exceeded. Please complete the captcha once again.